Silence Therapeutics
SLN
#8805
Rank
A$0.18 B
Marketcap
$3.93
Share price
-1.26%
Change (1 day)
-87.95%
Change (1 year)

Silence Therapeutics (SLN) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.11 Billion

According to Silence Therapeutics's latest financial reports the company's total liabilities are A$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Silence Therapeutics - Total liabilities on balance sheet (from 2024 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.11 B-39.47%
2023-12-31A$0.18 B-0.85%
2022-12-31A$0.18 B-16.57%
2021-12-31A$0.22 B18.56%
2020-12-31A$0.18 B200.64%
2019-12-31A$61.8 M605.79%
2018-12-31A$8.75 M40.88%
2017-12-31A$6.21 M82.8%
2016-12-31A$3.4 M0.92%
2015-12-31A$3.36 M-43.47%
2014-12-31A$5.96 M13.38%
2013-12-31A$5.25 M118.11%
2012-12-31A$2.41 M-18.72%
2011-12-31A$2.96 M-25.01%
2010-12-31A$3.95 M-35.44%
2009-12-31A$6.12 M115.36%
2008-12-31A$2.84 M-64.97%
2007-12-31A$8.12 M59.77%
2006-12-31A$5.08 M-15.6%
2005-12-31A$6.02 M49.6%
2004-12-31A$4.02 M-28.27%
2003-12-31A$5.61 M19.1%
2002-12-31A$4.71 M57.46%
2001-12-31A$2.99 M